| Neuroendocrine Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived168 of 168show fewer |
|---|
| → investigated in trials for | Etoposidesmall molecule 146 trials (58 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 146 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 132 trials (50 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 132 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 96 trials (32 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 96 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 66 trials (23 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 66 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 65 trials (37 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 65 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal_antibody 62 trials (26 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 62 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 57 trials (37 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 57 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal_antibody 41 trials (17 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 41 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall_molecule 39 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lurbinectedinsmall molecule 29 trials (20 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall_molecule 27 trials (11 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 26 trials (11 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tarlatamabmonoclonal antibody 26 trials (23 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall_molecule 23 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 20 trials (15 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 19 trials (6 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 16 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal_antibody 15 trials (9 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 14 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 14 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 13 trials (9 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 13 trials (6 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Serplulimabmonoclonal antibody 13 trials (9 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 13 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 12 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 12 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 12 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rovalpituzumab Tesirineadc 12 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Amrubicinsmall molecule 11 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 11 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vandetanibsmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall_molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Berzosertibsmall molecule 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall_molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selpercatinibsmall molecule 6 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal_antibody 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lutetium (177lu) Oxodotreotideother 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabazitaxelsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin OR Cisplatin 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall_molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralsetinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sugemalimabmonoclonal antibody 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Barasertibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cixutumumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elimusertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFIRI Regimen 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganetespibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Guadecitabinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumab/Nivolumab Regimen 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lucitanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Navtemadlinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall_molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegargiminaseother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Picoplatinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ponatinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talimogene Laherparepvecgene therapy 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vatalanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vistusertibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | 7-Ethyl-10-Hydroxycamptothecinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abirateronesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abiraterone Acetatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Amuvatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Apalutamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aurora A Kinase Inhibitor LY3295668 Erbumine 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin/Paclitaxel Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemoimmunotherapy 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chloroquinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daromun 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dinutuximabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dovitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enasidenibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzastaurinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Futibatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganitumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immune Checkpoint Inhibitor 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lifileucelcell therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Linsitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lomustinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Margetuximabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall_molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | PD-L1 Inhibitor 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal_antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Platinum Compound 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pomalidomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Porfimer 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prexasertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Radiation Therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rezatapoptsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rilotumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rucaparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tarextumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Teniposidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Therapeutic Tumor Infiltrating Lymphocytes 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tretinoinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinfluninesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zoledronic Acidsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |